Adrenal insufficiency (AI) manifests as a clinical syndrome arising from either the direct impairment of adrenal glands, leading to primary AI characterized by deficiencies in glucocorticoids and mineralocorticoids, or adrenal cortex atrophy due to diminished adrenocorticotropic hormone (ACTH) stimulation, a consequence of hypothalamic and/or pituitary damage, resulting in secondary AI. The diagnosis of AI is based on clinical assessment and biochemical tests, including basal hormone level measurements and stimulation tests. In evaluating the results of laboratory tests, it is necessary to consider factors that may influence both pre-analytical and analytical phases, as well as the chosen methodology. Correct diagnosis of adrenal insufficiency and timely initiation of suitable replacement therapy are paramount. These steps are crucial not only for managing the condition but also to avert potentially life-threatening adrenal crises.

3rd Department of Internal Medicine 1st Faculty of Medicine Charles University and General University Hospital Prague Czech Republic

Institute of Clinical Biochemistry and Laboratory Medicine 1st Faculty of Medicine Charles University and General University Hospital Prague Czech Republic

See more in PubMed

Arlt W, Allolio B. Adrenal insufficiency. Lancet 2003;361(9372):1881-93. DOI

Regal M, Páramo C, Sierra SM, Garcia-Mayor RV. Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain. Clin Endocrinol (Oxf) 2001;55(6):735-40. DOI

Lovas K, Husebye ES. High prevalence and increasing incidence of Addison's disease in western Norway. Clin Endocrinol 2002;56(6):787-9. DOI

Betterle C, Volpato M, Pedini B, Chen S, Smith BR, Furmaniak J. Adrenal-cortex autoantibodies and steroid-producing cells autoantibodies in patients Addison's disease: comparison of immunofluorescence and immunoprecipitation assays. J Clin Endocrinol Metab 1999;84:618-22. DOI

Betterle C, Dal Pra C, Mantero F, Zanchetta R. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr Rev 2002;23:327-64. DOI

Neufeld M, Maclaren NK, Blizzard RM. Two types of autoimmune Addison´s disease associated with different polyglandular autoimmune (PGA) syndromes. Medicine (Baltimor) 1981;60:355-62. DOI

Ahonen P, Myllarniemi S, Sipila I, Perheentupa J. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med 1990;322:1829-36. DOI

Perheentupa J. Autoimmune polyendocrinopathy- candidiasis-ectodermal dystrophy. J Clin Endocrinol Metab 2006;91:2843-50. DOI

Husebye ES, Anderson MS, Kämpe O. Autoimmune Polyendocrine Syndromes. N Engl J Med 2018;378(12):1132-41. DOI

Chen S, Sawicka J, Betterle C, Powell M, Prentice L, Volpato M, Rees Smith B, Furmaniak J. Autoantibodies to steroidogenic enzymes in autoimmune polyglandular syndrome, Addison's disease, and premature ovarian failure. J Clin Endocrinol Metab 1996;81(5):1871-6. DOI

Naletto L, Frigo ACh, Ceccato F. The natural history of autoimmune Addison's disease from the detection of autoantibodies to development of the disease: a long-term follow-up study on 143 patients Eur J Endocrinol 2019;180(3):223-34. DOI

Krone N, Dhir V, Ivison HE, Artl W. Congenital adrenal hyperplasia and P450 oxidoreductase deficiency. Clin Endocrinol 2007;66(2):162-72. DOI

Neocleous V, Fanis P, Phylactou LA, Skordis N. Genotype Is Associated to the Degree of Virilization in Patients With Classic Congenital Adrenal Hyperplasia. Front Endocrinol (Lausanne) 2018;9:733. DOI

White PC, Speiser PW. Congenital adrenal hyperplasia due to 21 - hydoxylase deficiency. Endocr Rev 2000;21(3):245-91. DOI

Mosser J, Douar AM, Sarde CO, Kioschis P, Feil R, Moser H, Poustka AM, Mandel JL, Aubourg P. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 1993;361(6414):726-30. DOI

Mosser J, Lutz Y, Stoeckel ME, Sarde CO, Kretz C, Douar AM, Lopez J, Aubourg P, Mandel JL. The gene responsible for adrenoleukodystrophy encodes a peroxisomal membrane protein. Hum Mol Genet 1994;3(2):265-71. DOI

Moser HW. Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy. Brain 1997;120:1485-508. DOI

Miller WL. Congenital lipoid adrenal hyperplasia: the human gene knockout for the steroidogenic acute regulatory protein. J Mol Endocrinol 1997;19(3):227-40. DOI

Miller WL. Androgen biosynthesis from cholesterol to DHEA. Mol Cell Endocrinol 2002;198(1-2):7-14. DOI

Peter M, Viemann M, Partsch CJ, Sippell WG, et al. Congenital Adrenal Hypoplasia: Clinical Spectrum, Experience with Hormonal Diagnosis, and Report on New Point Mutations of the DAX-1 Gene. J Clin Endocrinol Metab 1998;8(1):2666-74. DOI

Suntharalingham JP, Buonocore F, Duncan AJ, Achermann JC. DAX-1 (NR0B1) and steroidogenic factor-1 (SF-1, NR5A1) in human disease. Best Pract Res Clin Endocrinol Metab 2015;29(4):607-19. DOI

Meimaridou E, Hughes CR, Kowalczyk J, Chan LF, Clark AJ, Metherell LA. ACTH resistance: genes and mechanisms. Endocr Dev 2013;24:57-66. DOI

Dumic M, Barišic N, Kusec V, Stingl K, Skegro M, Stanimirovic A, Koehler K, Huebner A. Long-term clinical follow-up and molecular genetic findings in eight patients with triple A syndrome. Eur J Pediatr 2012;171(10):1453-9. DOI

Guran T, Buonocore F, Saka N. Rare Causes of Primary Adrenal Insufficiency: Genetic and Clinical Characterization of a Large Nationwide Cohort. J Clin Endocrinol Metab 2016;101(1):284-92. DOI

Piccioli A, Chini G, Mannelli M. Bilateral massive adrenal hemorrhage due to sepsis: report of two cases. J Endocrinol Invest 1994;170(10):821-4. DOI

Castinetti F, Nieman LK, Reincke. Approach to the Patient Treated with Steroidogenesis Inhibitors. J Clin Endocrinol Metab 2021;106(7):2114-23. DOI

Gray S, Bliski T, Dieudonne B. Hypopituitarism After Traumatic Brain Injury. Cureus 2019;11(3):e4163. DOI

Mody S, Brown MR, Parks JSl. The spectrum of hypopituitarism caused by PROP1 mutations. Best Pract Res Clin Endocrinol Metab 2002;16(3):421-31. DOI

Baker EH. Is there a safe and effective way to wean patients off long-term glucocorticoids? Br J Clin Pharmacol 2021;87(1):12-22. DOI

Sannarangappa V, Jalleh R. Inhaled Corticosteroids and Secondary Adrenal Insufficiency. Open Respir Med J 2014;8:93-100. DOI

González Villarroel P, Fernández Pérez I, Páramo C, Gentil González M, Carnero López B, Vázquez Tuñas ML, Carrasco Alvarez JA. Megestrol acetate-induced adrenal insufficiency. Clin Transl Oncol 2008;10(4):235-7. DOI

Dux S, Bishara J, Marom D, Blum I, Pitlik S. Medroxyprogestreone acetate induced secondary adrenal insufficiency. Ann Pharmacother 1998;32(1):134. DOI

Li T, Cunningham Jl, Gilliam WP, Loukianova L, Donegan DM. Bancos I. Prevalence of Opioid-Induced Adrenal Insufficiency in Patients Taking Chronic Opioids J Clin Endocrinol Metab 2020;105(10):e3766-e3775. DOI

Oelkers W. Hyponatremia and inappropriate secretion of vasopressin (antidiuretic hormone) in patients with hypopituitarism. N Engl J Med 1989;321(8):492-6. DOI

Mitchell AL, Pearce SH. Autoimmune Addison disease: pathophysiology and genetic complexity. Nat Rev Endocrinol 2012;8:306-16. DOI

Papierska L, Rabijewski M. Delay in diagnosis of adrenal insufficiency is a frequent cause of adrenal crisis. Int J Endocrinol 2013;2013:482370. DOI

Husebye ES, Allolio B, Arlt W, Badenhoop K, Bensing S, Betterle C, Falorni A, Gan EH, Hulting AL, Kasperlik-Zaluska A, Kämpe O, Løvås K, Meyer G, Pearce SH. Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency. J Intern Med 2014;275(2):104-15. DOI

Puar TH, Stikkelbroeck NM, Smans LC, Zelissen PM, Hermus AR. Adrenal crisis: still a deadly event in the 21st century. Am J Med 2016; 129(3):339.e1-9. doi: 10.1016/j.amjmed.2015.08.021 PubMed DOI

Arlt W, Callies F, van Vlijmen JC, Koehler I, Reincke M, Bidlingmaier M, Huebler D, Oettel M, Ernst M, Schulte HM, Allolio B. Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med 1999;341(14):1013-20. DOI

Nerup J. Addison's disease - clinical studies. A report for 108 cases. Acta Endocrinol (Copenh) 1974;76(1):127-41. DOI

Minisola S, Pepe J, Piemonte S, Cipriani C. The diagnosis and management of hypercalcaemia. BMJ 2015;350:h2723. DOI

Kato A, Shinozaki S, Goga T, Hishida A. Isolated adrenocorticotropic hormone deficiency presenting with hypercalcemia in a patient on long-term hemodialysis. Am J Kidney Dis 2003;42(2):E32-E36. DOI

Chanson P. Severe hyponatremia as a frequent revealing sign of hypopituitarism after 60 years of age. Eur J Endocrinol 2003;149:177-8. DOI

Selmaoui B, Touitou Y. Reproducibility of the circadian rhythms of serum cortisol and melatonin in healthy subjects: a study of three different 24-h cycles over six weeks. Life Sci 2003;73(26):3339-49. DOI

Verbeeten KC, Ahmet AH. The role of corticosteroid-binding globulin in the evaluation of adrenal insufficiency. J Pediatr Endocrinol Metab 2018;31(2):107-15. DOI

Hägg E, Asplund K, Lithner F. Value of basal plasma cortisol assays in the assessment of pituitary-adrenal insufficiency. Clin Endocrinol 1987(2);26:221-6. DOI

Schmidt IL, Lahner H, Mann K, Petersenn S. Diagnosis of adrenal insufficiency: evaluation of the corticotropin-releasing hormone test and basal serum cortisol comparison to the insulin tolerance test in patients with hypothalamic-pituitary-adrenal gland disease. J Clin Endocrinol Metab 2003;88(9):4193-8. DOI

Erturk E, Jaffe CA, Barkan AL. Evaluation of the integrity of the hypothalamic-pituitary-adrenal axis by insulin hypoglycemia test. J Clin Endocrinol Metab 1998;83:2350-4. DOI

Kazlauskaite R, Evans AT, Villabona CV, Abdu TA, Ambrosi B, Atkinson AB, Choi CH, Clayton RN, Courtney CH, Gonc EN, Maghnie M, Rose SR, Soule SG, Tordjman K; Consortium for Evaluation of Corticotropin Test in Hypothalamic-Pituitary Adrenal Insufficiency. Corticotropin tests for hypothalamic-pituitary- adrenal insufficiency: a metaanalysis. J Clin Endocrinol Metab 2008;93(11):4245-53. DOI

Gatti R, Antonelli G, Prearo M, Spinella P, Cappellin E, De Palo EF. Cortisol assays and diagnostic laboratory procedures in human biological fluids. Clin Biochem 2009;42(12):1205-17. DOI

Hawley JM, Owen LJ, MacKenzie F, Mussell C, Cowen S, Keevil BG. Candidate Reference Measurement Procedure for the Quantification of Total Serum Cortisol with LC-MS/MS. Clin Chem 2016;62(1):262-9. DOI

Kline GA, Buse J, Krause RD. Clinical implications for biochemical diagnostic threshold of adrenal sufficiency using a highly specific cortisol immunoassay. Clin Biochem 2017;50(9):475-80. DOI

Vogeser M, Kratzsch J, Ju Bae Y, Bruegel M, Ceglarek U, Fiers T, Gaudl A, Kurka H, Milczynski C, Prat Knoll C, Suhr AC, Teupser D, Zahn I, Ostlund RE. Multicenter performance evaluation of a second generation cortisol assay. Clin Chem Lab Med 2017;55(6):826-35. DOI

Grassi G, Morelli V, Ceriotti F, Polledri E, Fustinoni S, D'Agostino S, Mantovani G, Chiodini I, Arosio M. Minding the gap between cortisol levels measured with second-generation assays and current diagnostic thresholds for the diagnosis of adrenal insufficiency: a single-center experience. Hormones (Athens) 2020;19(3):425-31. DOI

Hawley JM, Owen LJ, Lockhart SJ, Monaghan PJ, Armston A, Chadwick CA, Wilshaw H, Freire M, Perry L, Keevil BG. Serum Cortisol: An Up-To-Date Assessment of Routine Assay Performance. Clin Chem 2016;62(9):1220-9. DOI

Keevil BG. LC-MS/MS analysis of steroids in the clinical laboratory. Clin Biochem 2016;49 (13-14):989-97. DOI

Monaghan PJ, Keevil BG, Stewart PM, Trainer PJ. Case for the wider adoption of mass spectrometry-based adrenal steroid testing, and beyond. J Clin Endocrinol Metab 2014;99 (12):4434-7. DOI

Lee MK, Vasikaran S, Doery JC, Wijeratne N, Prentice D. Cortisol: ACTH ratio to test for primary hypoadrenalism: a pilot study. Postgrad Med J 2013;89:617-20. DOI

Peccori GF, Saccani A, Cavagnini F. Assessment of ACTH assay variability: a multicenter study. Eur J Endocrinol 2011;164(4):505-12. DOI

Bornstein SR, Allolio B, Arlt W, Barthel A, Don-Wauchope A, Hammer GD, Husebye ES, Merke DP, Murad MH, Stratakis CA, Torpy DJ. Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2016;101(2):364-89. DOI

Saenger P, Levine LS, Irvine WJ, Gottesdiener K, Rauh W, Sonino N, Chow D, New MI. Progressive adrenal failure in polyglandular autoimmune disease. J Clin Endocrinol Metab 1982;54(4):863-7. DOI

Dorn LD, Lucke JF, Loucks TL, Berga SL. Salivary cortisol reflects serum cortisol: analysis of circadian profiles. Ann Clin Biochem 2007;44:281-4. DOI

Gröschl M. Current status of salivary hormone analysis. Clin Chem 2008;54(11):1759-69. DOI

Perogamvros I, Keevil BG, Ray DW, Trainer PJ. Salivary cortisone is a potential biomarker for serum free cortisol. J Clin Endocrinol Metab 2010;95(11):4951-8. DOI

Jonsson BAG, Malmberg B, Amilon A, Garde AH. Determination of cortisol in human saliva using chromatrography-electrospray tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2003;784(1):63-8. DOI

Perogamvros I, Owen LJ, Newell-Price J, Ray DW, Trainer PJ, Keevil BG. Simultaneous measurement of cortisol and cortisone in human saliva using liquid chromatography-tandem mass spectrometry: application in basal and stimulated conditions. J Chromatogr B Analyt Technol Biomed Life Sci 2009;877(29):3771-5. DOI

Deutschbein T, Broecker-Preuss M, Flitsch J, Jaeger A, Althoff R, Walz MK, Mann K, Petersenn S. Salivary cortisol as a diagnostic tool for Cushing's syndrome and adrenal insufficiency: improved screening by an automatic immunoassay. Eur J Endocrinol 2012;166(4):613-8. DOI

Snow K, Jiang NS, Kao PC, Scheithauer BW. Biochemical evaluation of adrenal dysfunction: the laboratory perspective. Mayo Clin Proc 1992;67(11):1055-65. DOI

de Miguel Novoa P, Vela ET, García NP, Rodríguez MM, Guerras IS, Martínez de Salinas Santamaría Mde L, Masó AA; Área de Conocimiento del Grupo de Neuroendocrino de la SEEN (Grupo Insuficiencia Adrenal). Guidelines for the diagnosis and treatment of adrenal insufficiency in the adult. Endocrinol Nutr 2014;61Suppl1:1-35. doi: 10.1016/S1575-0922(14)73526-0 (In English, Spanish) PubMed DOI

Kosak M, Duskova M, Starka L, Jandikova H, Pospisilova H, Sramkova M, Hana V, Krsek M, Springer D, Simunkova K. Can the gold standard be beaten? How reliable are various modifications of the Synacthen test compared to the insulin tolerance test. Physiol Res 2017;66(Suppl 3):S387-S395. DOI

Nye EJ, Grice JE, Hockings GI, Strakosch CR, Crosbie GV, Walters MM, Jackson RV. Comparison of adrenocorticotropin (ACTH) stimulation tests and insulin hypoglycemia in normal humans: low dose, standard high dose, and 8-hour ACTH-(1-24) infusion tests. J Clin Endocrinol Metab 1999;84(10):3648-55. DOI

Patel L, Clayton PE. Clinical usefulness of the low dose ACTH test. J Endocrinol Invest 1999;22:401-4. DOI

Rasmuson S, Olsson T, Hagg E. A low dose ACTH test to assess the function of the hypothalamic-pituitary-adrenal axis. Clin Endocrinol (Oxf) 1996:44(2):151-6. DOI

Ospina NS, Al Nofal A, Bancos I, Javed A, Benkhadra K, Kapoor E, Lteif AN, Natt N, Murad MH. ACTH Stimulation Tests for the Diagnosis of Adrenal Insufficiency: Systematic Review and Meta-Analysis. J Clin Endocrinol Metab 2016;101(2):427-34. DOI

Dekkers OM, Timmermans JM, Smit JW, Romijn JA, Pereira AM. Comparison of the cortisol responses to testing with two doses of ACTH in patients with suspected adrenal insufficiency. Eur J Endocrinol 2011;164(1):83-7. DOI

Jones SL, Trainer PJ, Perry L, Wass JA, Bessser GM, Grossman A. An audit of the insulin tolerance test in adult subjects in an acute investigation unit over one year. Clin Endocrinol (Oxf) 1994;41(1):123-8. DOI

Finucane FM, Liew A, Thornton E, Rogers B, Tormey W, Agha A. Clinical insights into the safety and utility of the insulin tolerance test (ITT) in the assessment of the hypothalamo-pituitary-adrenal axis. Clin Endocrinol (Oxf) 2008;69(4):603-7. DOI

Lee P, Greenfield JR, Ho KKY. Factors determining inadequate hypoglycaemia during insulin tolerance testing (ITT) after pituitary surgery. Clin Endocrinol (Oxf) 2009;71(1):82-5. DOI

Fish HR, Chernow B, O'Brian JT. Endocrine and neurophysiologic responses of the pituitary to insulin-induced hypoglycemia: a review. Metabolism 1986;35(8):763-80. DOI

Hurel SJ, Thompson CJ, Watson MJ, Harris MM, Baylis PH, Kendall-Taylor P. The short Synacthen and insulin stress tests in the assessment of the hypothalamic-pituitary-adrenal axis. Clin Endocrinol 1996;44(2):141-6. DOI

Cho HY, Kim JH, Kim SW, Shin CS, Park KS, Yang HC, Kim SY. Different cut-off values of the insulin tolerance test, the high-dose short Synacthen test (250μg) and the low-dose short Synacthen test (1μg) in assessing central adrenal insufficiency. Clin Endocrinol 2014;81(1):77-84. DOI

Fleseriu M, Hashim IA, Karavitaki N, Melmed S, Murad MH, Salvatori R, Samuels MH. Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2016;101(11):3888-921. DOI

Berg Ch, Meinel T, Lahner H, Yuece A, Mann K, Petersenn S. Diagnostic utility of the glucagon stimulation test in comparison to the insulin tolerance test in patients following pituitary surgery. Eur J Endocrinol 2010;162(3):477-82. DOI

Ach T, Yosra H, Jihen M, Abdelkarim Asma B, Maha K, Molka C, Rouatbi S, Monia Z, Ach K. Cortisol cut-points for the glucagon stimulation test in the evaluation of hypothalamic pituitary adrenal axis. Endocr J 2018;65(9):935-42. DOI

Hamrahian AH, Yuen KC, Gordon MB, Pulaski-Liebert KJ, Bena J, Biller BM. Revised GH and cortisol cut-points for the glucagon stimulation test in the evaluation of GH and hypothalamic-pituitary-adrenal axes in adults: Results from a prospective randomized multicenter study. Pituitary 2016;19,332-41. DOI

Cousins L, Rigg L, Hollongsworth D, Meis P, Halberg F, Brink G, Yen SS. Qualitative and quantitative assessment of the circadian rhythm of cortisol in pregnancy. Am J Obstet Gynecol 1983;145(4):411-6. DOI

Jung C, Ho JT, Torpy DJ, Rogers A, Doogue M, Lewis JG, Czajko RJ, Inder WJ. A longitudinal study of plasma and urinary cortisol in pregnancy and postpartum. J Clin Endocrinol Metab 2011;96(5):1533-40. DOI

Bjornsdottir S, Cnattingius S, Brandt L, Nordenstrom A, Ekbom O, Kampe O, Bensing S. Addison's disease in women is a risk factor for an adverse pregnancy outcome. J Clin Endocrinol Meteb 2010;95(12):5249-57. DOI

Lebbe M, Arlt W. What is the best diagnostic and therapeutic management strategy for an Addison patient during pregnancy? Clin Endocrinol 2013;88(4):497-502. DOI

Maier B, Vogeser M. Target analyte quantification by isotope dilution LC-MS/MS directly referring to internal standard concentrations-validation for serum cortisol measurement. Clin Chem Lab Med 2013;51(4):833-7. DOI

Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, Merke DP, Meyer-Bahlburg HF, Miller WL, Montori VM, Oberfield SE, Ritzen M, White PC; Endocrine Society. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2010;95(9):4133-60. doi: 10.1210/jc.2009-2631. Erratum in: J Clin Endocrinol Metab 2010;95(11):5137. Erratum in: J Clin Endocrinol Metab 2021;106(7):e2853. PubMed DOI

Baumgartner-Parzer SM, Nowotny P, Heinze G, Waldhäusl W, Vierhapper H. Carrier frequency of congenital adrenal hyperplasia (21-hydroxylase deficiency) in a middle European population. J Clin Endocrinol Metab 2005;90(2):775-8. DOI

Sabina Baumgartner-Parzer S, Witsch-Baumgartner M, Hoeppner W. EMQN best practice guidelines for molecular genetic testing and reporting of 21-hydroxylase deficiency. EJHG 2020;28:1341-67. DOI

Owen LJ, Halsall DJ, Keevil BG. Cortisol measurement in patients receiving metyrapone therapy. Ann Clin Biochem 2010;47:573-5. DOI